EN
HI
Akums Drugs & Pharmaceuticals share price chart
Akums Drugs & Pharmaceuticals Share Key Metrics
Volume
21.85 L
Market Cap
11491.34 CR
LTQ@LTP
36@730.10
ATP
734.18
Var Margin
17.4 %
Circuit Range
627.75-767.15
Delivery %
56.13 %
Value
160.43 CR
ASM/GSM
No
Market Lot
1
Summary
AKUMS stock price is ₹730.1 as of 10 Aug, 2026. The stock intraday movement has stayed between ₹703.00 and ₹756.85, while Akums Drugs & Pharmaceuticals share price 52 week high low is ₹409.30 & ₹756.85.
In terms of trading activity, AKUMS share price has recorded a volume of 21,85,132 shares. The Akums Drugs & Pharmaceuticals has a market cap of ₹157393988. The stock’s Average Traded Price (ATP) stands at ₹734.18, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 36 @ ₹730.10.
The Akums Drugs & Pharmaceuticals upper circuit limit is ₹767.15 & The Akums Drugs & Pharmaceuticals lower circuit limit is ₹627.75, with a Value of ₹160.43 CR. The Delivery Percentage for the day is 56.13%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Akums Drugs & Pharmaceuticals Fundamentals
P/E Ratio
37.58
P/B Ratio
3.21
Div. Yield
0.43
Sector P/E
64.26
Sector P/B
3.23
Sec. Div. Yield
0.51
Akums Drugs & Pharmaceuticals Resistance and Support
Pivot 688.77
Resistance
First Resistance
711.69
Second Resistance
725.92
Third Resistance
748.84
Support
First Support
674.54
Second Support
651.62
Third Support
637.39
Akums Drugs & Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 10 2026 | 710.1 | 730.1 | 4.68% | 756.85 | 703 |
| Fri Aug 07 2026 | 672 | 697.45 | 5.27% | 703 | 665.84 |
| Thu Aug 06 2026 | 670 | 662.54 | -0.53% | 670.95 | 656.5 |
Akums Drugs & Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-08 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals News
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Akums Drugs & Pharma announced the availability of the audio recording for its Investors/Analysts Conference Call, held on August 10, 2026, to discuss the un-audited financial results for Q1 FY27. The transcript will also be made available in due course.
Aug 10 2026 15:43:07
Akums Drugs and Pharmaceuticals Ltd - 544222 - Press Release
Akums Drugs & Pharma reported robust Q1 FY27 consolidated financial results. Revenue grew 13.9% YoY to Rs.1,167 crore, while PAT surged 55.4% YoY to Rs.101 crore, supported by strong CDMO business performance and improved margins.
Aug 08 2026 17:06:44
Read More
Akums Drugs & Pharmaceuticals Management
| Name | Position |
|---|---|
| Sanjeev Jain | Managing Director |
| Sandeep Jain | Managing Director |
Akums Drugs & Pharmaceuticals Similar Stocks
Marksans Pharma Ltd.
271.45
-2.40 (0.88%)
Viyash Scientific Ltd.
273.65
-3.35 (1.21%)
Metropolis Healthcare Ltd.
572.65
9.45 (1.68%)
Sanofi Consumer Healthcare India Ltd.
4505.90
-8.30 (0.18%)
Blue Jet Healthcare Ltd.
592.15
-1.75 (0.29%)
Sudeep Pharma Ltd.
1053.30
95.75 (10.00%)
Jupiter Life Line Hospitals Ltd.
320.00
-0.20 (0.06%)
Healthcare Global Enterprises Ltd.
715.65
39.80 (5.89%)
Thyrocare Technologies Ltd.
622.10
18.85 (3.12%)
Strides Pharma Science Ltd.
999.00
-4.80 (0.48%)
Akums Drugs & Pharmaceuticals FAQs
The Buying Price of Akums Drugs & Pharmaceuticals share is 730.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Akums Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Akums Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 37.58. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 3.21. Useful to assess the stock's value relative to its book value.
To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.26 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Akums Drugs & Pharmaceuticals is 11491.34 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 756.85 & 409.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Akums Drugs & Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
